Bogotá, Capital District, Colombia
Marketing professional with proven experience in business development and planning of marketing strategies for the pharmaceutical industry, identifying needs and obtaining growth in sales and market share ensuring profitability. Additionionally, I have operational skills in sales and finance management as well as strategic thinking, team leadership and achievement orientation. I easily relate with internal and external clients to work effectively as a team to obtain quick wins and results.
Carry out the planning and implementation of marketing plans for brands in charge. Generate business plans to support the rotation of Microgynon in distributors and wholesalers; as well as the evacuation at point of sale. Develop marketing strategies, campaigns and promotional materials for brands under my responsibility, as well as ensuring their effective execution at the field. Coordination and management of users generation plan for Microgynon. Achievements: • Reversed the decreasing trend in internal sales with Microgynon 30 (a brand that represented 42% of sales in values) obtaining a 9% growth in units and 12.5% in values as of March 2018 compared to Q1/17 . •Generated innovative visual campaign for medical visit with Microgynon Suave (brand with 19 years in the market) where it was possible to recover with the doctor the positioning of the brand and prescription. •Developed and implemented two rotation programs for pharmacies that allowed to increase the value of effective transfers per person by 25% with Microgynon Q1 / 18 vs. Q4 / 17.
Perform planning and implementation of marketing plans for oral contraceptives as well as evaluation of business opportunities to complement the portfolio with new brands. Carry out the coordination of training materials to guarantee the optimum level of knowledge of the sales force. Develop marketing strategies, campaigns and promotional materials as well as ensure their effective execution in the field. Generate an investment plan and ensure its execution to achieve profitable growth. Follow up of the registration activities as well as the pharmacovigilance program. • Successfully launched the company during the thirtieth National Congress of Gynecology impacting 1600 specialists during the inaugural cultural event with exclusiveness for Exeltis. • Generated an expectation campaign to introduce and position Exeltis as a European Pharmaceutical laboratory as well as its products, achieving a growth in total prescriptions of 220% Q4 / 16 vs Q3 / 16 (launch quarter). • Obtained growth of 345% turnover on launched portafolio in major clients comparing Q4 / 16 against previous period Q3 /16(launch quarter). • Achieved 90% of target launch schedule of the 10 brands in charge; obeying the missing 10% to delay in obtaining registration in INVIMA. • Developed interactive visual aid that allows the use of smart grills which simplify to the sales force doing tailored calls that meet the needs and prescriptive habits of each physician.
The planning and execution of the marketing strategy for the portfolio of products in charge with a value of $95,000 million pesos in sales and an investment budget of $ 2,500 million. Optimize the management of the assigned portfolio, defining the right mix of investment in the targets to ensure profitable growth. • Developed and implemented App in Education and Sexual Rights of the Computadores para Educar program to be used in 2 million tablets (country wide), increasing awareness among young people and the Colombian population about contraceptive methods (released Sept / 15). • Achieved a 16% increase in values and 13% in units in the Mirena / Jaydess long-term endoceptives accumulated to Sept / 15 compared to the same period of the previous year.
The planning and implementation of the strategy for the franchise of products in charge with a value in sales of $47,000 and $ 1,500 million investment. Develop strategic direction of campaigns and materials for medical promotion and follow up on the implementation of strategies in the field. Generate strategic vision for institutional work with antibiotics (Cipro / Avelox). • Increased by 6% sales (Year End 2014 values)of the total portfolio of $ 47.00 million, minimizing a negative impact of $ 9,000 million pesos due to manufacturing shortages due to the plant in Venezuela ( + 16% Analgesics, + 11% Antibiotics and + 10% Men's Health). • Capitalized Avelox's entry to the POS in Pneumonia, obtaining a growth of 25% in units and 22% in securities at the end of 2014. • Converted Cipro IV's sales mix by increasing Cipro 400mg's share from 36.6% at the end of 2013 to 41.3% at the end of 2014 and thus protecting sales from lower-priced copies of Cipro.
Perform the strategic planning for the assigned line and optimize the investment mix in the targets ensuring a profitable growth of the line. Develop the strategy, promotional materials and supervise their implementation in the field. • Achieved a 5% growth in values in the Tail Products portfolio (mature brands) with a saving of 55% in budgeted investment for 2011. • Reversed decreasing trend of Mesigyna (sales IMS) in the injectable contraceptive market at the end of 2011
Generate and implement marketing plans, creation and followup of special programs and promotional campaings and optimize media plan for brands in charge.
Desarrollar la planeación, administración y dirección a nivel nacional de las fuerzas de ventas de los negocios de Salud de la Mujer y Endocrinología optimizando sus KPI´s y direccionamiento del programa de educadoras en diabetes para apalancar el valor agregado a pacientes y aseguradores
Desarrollar e implementar el plan de mercadeo, análisis e interpretación tendencia del mercado y elaboración de campañas y materiales promocionales de productos a cargo. Seguimiento y control P y G.